Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Application Form
Contact
Imprint
Privacy Policy
Disclaimer
Supplier & partners
Contact
English
Deutsch
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Application Form
Show all
2022
2021
2020
2019
2018
2017
2016
Press Releases and Ad-hoc Announcements
02 June 2016
PR: WILEX AG announces change on the Executive Management Board
PDF
Read More
25 April 2016
PR: WILEX AG successfully completes capital increase
PDF
Read More
14 April 2016
PR: WILEX AG: Interim management statement on the first quarter of 2016
PDF
Read More
06 April 2016
PR: WILEX AG plans change on Supervisory Board
PDF
Read More
22 March 2016
PR: WILEX announces financial figures for the 2015 financial year and reports on course of business
PDF
Read More
02 February 2016
PR: WILEX AG: US-patent office granted patent for amatoxin conjugates for tumour therapy
PDF
Read More
13 January 2016
PR: WILEX’s partner Link Health submits IND application for clinical Phase I with the uPA inhibitor MESUPRON® in China
PDF
Read More
1
2
3
4
5
Imprint
Privacy Policy
Disclaimer
Supplier & partners
© Heidelberg Pharma AG. All rights reserved.